CTSO
Cytosorbents Crp
3.80$
+1.6%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -500.0% | -500.0% | – | – | – | – | – | -10,611.8% | -2,385.9% | -424.6% | -211.8% | -222.1% | -82.0% | -48.3% | -53.5% | -73.6% | -14.2% | -34.9% | -81.4% | -69.7% | -40.5% | -33.4% | |
| 100.0% | 100.0% | – | – | – | – | – | 108.5% | 36.0% | 7.8% | 2.1% | 2.8% | 2.0% | 1.6% | 1.9% | 2.6% | 1.7% | 2.8% | 3.3% | 6.5% | 4.9% | 4.4% | |
| – | – | – | – | – | – | – | – | 41.6% | 8.0% | 22.1% | 9.4% | 33.6% | 24.8% | 26.6% | 12.5% | 11.9% | 15.5% | 11.0% | 11.9% | 10.6% | 7.5% | |
| – | – | – | – | – | – | – | – | – | 63.6% | 107.6% | 19.0% | 44.0% | 19.1% | 33.7% | 14.3% | 5.1% | 21.9% | 20.2% | – | – | – | |
| -800.0% | -800.0% | – | – | – | – | – | -546.0% | -357.6% | 35.3% | -19.1% | -10.2% | 20.2% | -1.2% | -4.6% | -6.4% | -1.9% | 1.6% | -10.3% | 7.6% | -12.3% | -2.8% | |
| 0.0% | 0.0% | – | – | – | – | – | 145.5% | 25.6% | 26.3% | 11.7% | 15.9% | 7.3% | 12.5% | 7.5% | 6.7% | 4.2% | 10.7% | 18.6% | 3.0% | 0.8% | 0.4% | |
| – | – | – | – | – | – | – | -145.5% | -25.6% | -26.3% | -73.5% | -22.0% | 19.5% | -12.5% | -7.5% | -6.7% | -4.2% | -10.7% | -18.6% | -3.0% | -1.9% | -1.1% | |
| – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.5% | – | – | – | – | 14.4% | – | – | – | |
| – | – | – | – | – | – | – | 1,110.1% | 0.0% | 19.4% | 0.0% | 287.0% | 2.2% | 113.0% | 17.2% | 11.0% | 3.8% | -0.2% | -0.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | 224.3% | 159.0% | 123.3% | 60.9% | 37.4% | -0.7% | 22.0% | -38.0% | 12.5% | 14.4% | 0.0% | 28.1% | 6.7% | |
| 400.0% | 400.0% | – | – | – | – | – | 11,120.4% | 2,777.9% | 511.4% | 318.5% | 287.0% | 61.7% | 150.4% | 86.2% | 35.9% | 168.2% | 1.8% | 14.3% | 46.6% | 26.2% | 25.1% | |
| -200.0% | -200.0% | – | – | – | – | – | 363.1% | 358.0% | 55.2% | 45.2% | 42.2% | -0.9% | 90.2% | 24.9% | -44.5% | 150.0% | -43.9% | -86.5% | -26.4% | -16.4% | -5.4% | |
| -500.0% | -500.0% | – | – | – | – | – | -10,757.3% | -2,411.5% | -450.9% | -223.5% | -238.0% | -89.3% | -60.8% | -61.0% | -80.3% | -18.5% | -45.6% | -100.0% | -72.7% | -41.3% | -33.8% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.